Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair.
Saved in:
| Title: | Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair. |
|---|---|
| Authors: | Meriwether D; Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: dmeriwether@mednet.ucla.edu., Jones AE; Department of Medical and Molecular Pharmacology, University of California, Los Angeles, Los Angeles, California., Ashby JW; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Solorzano-Vargas RS; Division of Gastroenterology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Dorreh N; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Noori S; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Grijalva V; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Ball AB; Department of Medical and Molecular Pharmacology, University of California, Los Angeles, Los Angeles, California., Semis M; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Divakaruni AS; Department of Medical and Molecular Pharmacology, University of California, Los Angeles, Los Angeles, California., Mack JJ; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Herschman HR; Department of Medical and Molecular Pharmacology, University of California, Los Angeles, Los Angeles, California., Martin MG; Division of Gastroenterology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Fogelman AM; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California., Reddy ST; Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California; Department of Medical and Molecular Pharmacology, University of California, Los Angeles, Los Angeles, California. Electronic address: sreddy@mednet.ucla.edu. |
| Source: | Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2022; Vol. 13 (4), pp. 1095-1120. Date of Electronic Publication: 2022 Jan 10. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: American Gastroenterological Association Country of Publication: United States NLM ID: 101648302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-345X (Electronic) Linking ISSN: 2352345X NLM ISO Abbreviation: Cell Mol Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
